Author: Bryan Clark / Source: The Next Web
A blood test could one day save millions by allowing doctors to screen for cancer before patients show symptoms.
The test, called a “liquid biopsy,” screens for 10 types of the disease by detecting trace amounts of DNA released into the bloodstream by cancer cells.
So far, it has proven particularly capable of detecting ovarian and pancreatic cancer, both of which have significantly lower mortality rates when caught early enough to perform surgery as a means of removing the cancer. Unfortunately, most are caught after patients begin to show symptoms, which is often after the cancer has spread to other parts of the body.“This is potentially the holy grail of cancer research, to find cancers that are currently hard…
The post New blood test could be the ‘holy grail of cancer research’ appeared first on FeedBox.